William T. Whelan: Lawyer with Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

William T. Whelan

Phone617.348.1869

Peer Rating
 5.0/5.0
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Mergers & Acquisitions
  • Securities
  • Corporate Governance
  • Start-Ups
  • Joint Ventures
  • Strategic Alliances
  • Collaborations & Technology Transfer
  • Life Sciences
  • Technology
  • Communications & Media
  • Energy Technology
  • Medical Technology
 
Contact InfoTelephone: 617.348.1869
Fax: 617-542-2241
Internet: Each Attorney's Internet Address takes the following form: first initial, last name @mintz.com (e.g., rmintz@mintz.com)

http://www.mintz.com/professionals/detail/name/william-t-whelan
http://www.mintz.com/videos/financing-trends-in-life-sciences
http://www.mintz.com/videos/transformation-of-the-vc-business-model
http://www.mintz.com/videos/innovative-exit-strategies-in-life-sciences
 
University Middlebury College, B.A.
 
Law SchoolBoston University, J.D.
 
Admitted1983, Massachusetts
 
Memberships 

• Past member, MIT Innovations Committee
• Member, American Bar Association
• Member, Massachusetts Bar Association
• Member, Boston Bar Association

 
LanguagesFrench
 
Biography

Bill serves as Co-chair of the firm's Life Sciences Practice. He focuses his practice on securities law, venture capital, and mergers and acquisitions. He regularly represents technology-based companies, principally in the areas of biotechnology, medical technologies, energy and clean technology, and software. He routinely counsels these clients on many aspects of their corporate development, from initial organization and acquisition of technology, through private financing and initial public offering, to strategic alliances and business combination transactions. He also regularly represents venture capital firms in portfolio investment activities and underwriters in public offerings and private placements of equity securities.

Bill has lectured at various Massachusetts Continuing Legal Education seminars on topics relating to corporate organization and mergers and acquisitions.

During law school, he served as editor-in-chief of theBoston University Law Review. Bill is a former law clerk to the Chief Judge of the US Court of Appeals for the District of Columbia Circuit.

Newsroom

• Fifty-One Mintz Levin Attorneys Featured in Chambers USA 2014 Guide, (05.23.2014)

• Mintz Levin Named Biotechnology Law Firm of the Year- North America by M&A Today Global Awards, (02.20.2014)

• Sixty-Three Mintz Levin Attorneys Included in The Best Lawyers in America, 2014 Edition, (08.15.2013)

• Mintz Levin Represents Intercept Pharmaceuticals Inc. in Follow-On Public Offering, (07.01.2013)

• Eleven Mintz Levin Attorneys and Six Practice Areas Recommended by Legal 500 United States 2013, (06.18.2013)

• Sixty Mintz Levin Attorneys Included in The Best Lawyers in America, 2013 Edition, (08.24.2012)

• Mintz Levin's Life Sciences Practice Represents Boston Biomedical, Inc. in its Agreement with Dainippon Sumitomo Pharma Co., Ltd. to be Acquired for up to $2.63 Billion, (03.02.2012)

• Mintz Levin Represents Caliper Life Sciences in $600 Million Acquisition by PerkinElmer, (11.08.2011)

• Mintz Levin Represents BG Medicine in Closing of Initial Public Offering, (02.10.2011)

• William T. Whelan to moderate panel discussion at AdvaMed 2008 - The MedTech Conference, (09.23.2008)

Recognitions & Awards


Chambers USA: Massachusetts - Corporate/Mergers & Acquisitions (2014)
• Recommended byThe Legal 500 United Statesfor Healthcare: Life Sciences (2013)
Best Lawyers in America: Biotechnology Law (2013 - 2014)
• Martindale-Hubbell AV Preeminent

Speaking Engagements

Moderator,Private Financing Trends,2014 CEO Conference, Boston Biotech Conferences, Boston, MA (06.05.2014)

• Moderator,Deal Structures,Boston CEO Conference, Boston, MA (06.12.2012)

• Moderator,Funding for Your Start-Up Life Sciences Company, The Capital Network and the Mass Technology Leadership Council, Boston, MA (03.11.2009)

 
Reported CasesRepresentative Matters: Mergers & Acquisitions Represented Ember Corporation in its merger with Silicon Laboratories, Inc. (NASDAQ: SLAB); Represented Pluromed, Inc. in its merger with Sanofi; Represented Boston Biomedical, Inc. in its merger with Dainippon Sumitomo Pharma Co., Ltd. Represented Caliper Life Sciences, Inc. (Nasdaq: CALP) in its merger with PerkinElmer, Inc. (NYSE: PKI); Represented Visigen Biotechnologies, Inc. in its merger with Invitrogen Corporation (currently known as Life Technologies, Inc. (Nasdaq: LIFE)); Represented V.I. Technologies, Inc. (Nasdaq: VITX) in its merger with Panacos Pharmaceuticals, Inc. (Nasdaq: PANC); Represented EPIX Pharmaceuticals, Inc. (Nasdaq: EPIX) in its merger with Predix Pharmaceuticals, Inc. Represented Caliper Life Sciences, Inc. (Nasdaq: CALP) in its merger with Xenogen Corporation (Nasdaq: XGEN); Represented Focus Technologies Holding Company in its acquisition by Quest Diagnostics Incorporated (NYSE: DGX); Represented the MacGregror Group, Inc. in its acquisition by Investment Technology Group, Inc. (NYSE: ITG) Public & Private Offerings for Public Companies Represented Intercept Pharmaceuticals, Inc. (Nasadq: ICPT) in its initial public offering; Represented BG Medicine, Inc. (Nasdaq: BGMD) in its initial public offering; Represented Coley Pharmaceutical Group, Inc. (Nasdaq: COLY) in its initial public offering; Represented Panacos Pharmaceuticals, Inc. (Nasdaq: PANC) in a follow-on public offering; Represented EPIX Pharmaceuticals, Inc. (Nasdaq: EPIX) in its initial public offering and a Rule 144A offering of convertible notes; Represented Predix Pharmaceuticals, Inc. in its initial public offering Venture Capital Financings Represented Anchor Therapeutics, Inc. in various preferred stock and debt financings; Represented BG Medicine, Inc. in various preferred stock and debt financings; Represented Aureon Laboratories, Inc. in various preferred stock and debt financings; Represented Pulmatrix, Inc. in various preferred stock and debt financings; Represented Luminus Devices, Inc. in various preferred stock and debt financings
 
ISLN902815221
 


View Ratings & Reviews
Profile Visibility
#673 in weekly profile views out of 19,030 lawyers in Boston, Massachusetts
#43,293 in weekly profile views out of 1,519,763 total lawyers Overall

Office Information

William T. Whelan


BostonMA 02111




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now